Vident Investment Advisory’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-62,953
Closed -$5.93M 355
2023
Q2
$5.93M Sell
62,953
-18,364
-23% -$1.73M 0.2% 140
2023
Q1
$6.73M Buy
81,317
+71,423
+722% +$5.91M 0.22% 136
2022
Q4
$738K Sell
9,894
-8,062
-45% -$602K 0.03% 577
2022
Q3
$1.17M Buy
17,956
+4,804
+37% +$312K 0.04% 541
2022
Q2
$1.25M Buy
13,152
+3,186
+32% +$304K 0.04% 559
2022
Q1
$1.17M Sell
9,966
-1,065
-10% -$125K 0.03% 629
2021
Q4
$1.43M Sell
11,031
-7,237
-40% -$938K 0.04% 588
2021
Q3
$2.07M Buy
18,268
+7,167
+65% +$812K 0.06% 391
2021
Q2
$1.15M Sell
11,101
-21,486
-66% -$2.23M 0.03% 619
2021
Q1
$2.73M Buy
32,587
+15,481
+91% +$1.29M 0.09% 236
2020
Q4
$1.56M Sell
17,106
-309
-2% -$28.2K 0.06% 386
2020
Q3
$1.39M Buy
17,415
+980
+6% +$78.2K 0.07% 397
2020
Q2
$1.14M Buy
16,435
+12,493
+317% +$864K 0.06% 437
2020
Q1
$248K Buy
+3,942
New +$248K 0.02% 721
2019
Q1
Sell
-6,189
Closed -$316K 751
2018
Q4
$316K Sell
6,189
-6,483
-51% -$331K 0.02% 699
2018
Q3
$735K Buy
+12,672
New +$735K 0.03% 566
2018
Q2
Sell
-27,057
Closed -$1.25M 930
2018
Q1
$1.25M Sell
27,057
-4,464
-14% -$205K 0.05% 358
2017
Q4
$1.18M Sell
31,521
-2,190
-6% -$82.3K 0.05% 356
2017
Q3
$1.23M Buy
+33,711
New +$1.23M 0.07% 341
2016
Q4
Sell
-12,483
Closed -$502K 387
2016
Q3
$502K Buy
+12,483
New +$502K 0.07% 344
2015
Q4
Sell
-85,686
Closed -$2.03M 526
2015
Q3
$2.03M Buy
85,686
+84,432
+6,733% +$2M 0.28% 80
2015
Q2
$30K Buy
+1,254
New +$30K ﹤0.01% 867